Brief: Ramm Pharma Corp Announces Non-Brokered Private Placement And Intention To Commence Normal Course Issuer Bid05/09/2023 22:53
Brief: RAMM Pharma Initiates Clinical Trials Of Its Proprietary Nettavet Cannabinoid Formulation25/03/2021 11:42
Brief: Ramm Pharma Enters European Cannabis Market With Strategic Investment In Canapar Corp.30/12/2020 22:29